Evidence map›Paper›PMID 26100018›Full record

ArticleMolecular and cellular biology2015

XRCC4/XLF Interaction Is Variably Required for DNA Repair and Is Not Required for Ligase IV Stimulation.

Sunetra Roy, Abinadabe J de Melo, Yao Xu, Satish K Tadi, Aurélie Négrel, Eric Hendrickson, Mauro Modesti, Katheryn Meek

Open access · bronzeAbstract read
In one paragraph

Article in Molecular and cellular biology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 42 papers.

0numbers the graph read from it
0cells of the map it votes in
42citing papers in PubMed
4.1field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

42 citing papers in PubMed, 62 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. DNA repair and anti-cancer mechanisms in the long-lived bowhead whale.bioRxiv : the preprint server for biology · 2024
    Article
  5. Article
  6. Review
  7. Article
  8. Review
  9. Phosphorylation of DNA-PKcs at the S2056 cluster ensures efficient and productive lymphocyte development in XLF-deficient mice.Proceedings of the National Academy of Sciences of the United States of America · 2023
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Review
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 4 institutions in 2 countries.

Sunetra RoyCollege of Veterinary Medicine and Departments of Microbiology & Molecular Genetics and Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.
Abinadabe J de MeloCentre de Recherche en Cancérologie de Marseille, CNRS, UMR7258, Marseille, France INSERM, U1068, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France.
Yao XuCollege of Veterinary Medicine and Departments of Microbiology & Molecular Genetics and Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA.
Satish K TadiCentre de Recherche en Cancérologie de Marseille, CNRS, UMR7258, Marseille, France INSERM, U1068, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France.
Aurélie NégrelCentre de Recherche en Cancérologie de Marseille, CNRS, UMR7258, Marseille, France INSERM, U1068, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France.
Eric HendricksonDepartment of Biochemistry, Molecular Biology and Biophysics, University of Minnesota Medical School, Minneapolis, Minnesota, USA.
Mauro ModestiCentre de Recherche en Cancérologie de Marseille, CNRS, UMR7258, Marseille, France INSERM, U1068, Marseille, France Institut Paoli-Calmettes, Marseille, France Aix-Marseille Université, Marseille, France.
Katheryn MeekCollege of Veterinary Medicine and Departments of Microbiology & Molecular Genetics and Pathobiology & Diagnostic Investigation, Michigan State University, East Lansing, Michigan, USA kmeek@msu.edu.
Michigan State University · USCentre de Recherche en Cancérologie de Marseille · FRInstitut Paoli-Calmettes · FRUniversity of Minnesota Medical Center · US

Funding

Relevant Targets of the DNA Dependent Protein KinaseR01AI048758 · NIAID · MICHIGAN STATE UNIVERSITY · PI MEEK, KATHERYN D · 2000 to 2016
$5.2M
The mechanism of Cas9/CRISPR-initiated genome modification in human somatic cellsR01GM088351 · NIGMS · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2010 to 2018
$2.3M
Ligase III regulates survival from crisis induced by gradual telomere shorteningR01CA190492 · NCI · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2015 to 2019
$1.7M
Ku regulates non-homologous end joining pathways in human somatic cellsR01CA154461 · NCI · UNIVERSITY OF MINNESOTA · PI HENDRICKSON, ERIC A · 2011 to 2015
$1.6M
NCI NIH HHS CA154461NCI NIH HHS R01 CA154461NCI NIH HHS R01 CA190492NIAID NIH HHS AI048758NIAID NIH HHS R01 AI048758NIGMS NIH HHS GM088351NIGMS NIH HHS R01 GM088351
6 · The paper itself

Abstract

The classic nonhomologous end-joining (c-NHEJ) pathway is largely responsible for repairing double-strand breaks (DSBs) in mammalian cells. XLF stimulates the XRCC4/DNA ligase IV complex by an unknown mechanism. XLF interacts with XRCC4 to form filaments of alternating XRCC4 and XLF dimers that bridge DNA ends in vitro, providing a mechanism by which XLF might stimulate ligation. Here, we characterize two XLF mutants that do not interact with XRCC4 and cannot form filaments or bridge DNA in vitro. One mutant is fully sufficient in stimulating ligation by XRCC4/Lig4 in vitro; the other is not. This separation-of-function mutant (which must function as an XLF homodimer) fully complements the c-NHEJ deficits of some XLF-deficient cell strains but not others, suggesting a variable requirement for XRCC4/XLF interaction in living cells. To determine whether the lack of XRCC4/XLF interaction (and potential bridging) can be compensated for by other factors, candidate repair factors were disrupted in XLF- or XRCC4-deficient cells. The loss of either ATM or the newly described XRCC4/XLF-like factor, PAXX, accentuates the requirement for XLF. However, in the case of ATM/XLF loss (but not PAXX/XLF loss), this reflects a greater requirement for XRCC4/XLF interaction.

Indexed as

Ataxia Telangiectasia Mutated ProteinsBase SequenceCell Line, TumorDNADNA-Binding ProteinsDNA Breaks, Double-StrandedDNA Ligase ATPDNA LigasesDNA RepairDNA Repair EnzymesHCT116 CellsHEK293 CellsHumansSequence Analysis, DNAV(D)J RecombinationAtaxia Telangiectasia Mutated ProteinsATM protein, humanDNADNA-Binding ProteinsDNA Ligase ATPDNA LigasesDNA Repair EnzymesLIG4 protein, humanNHEJ1 protein, humanPAXX protein, humanXRCC4 protein, human

Identifiers

PMID26100018
PMCPMC4525314
OpenAlexW2129436075

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.